111, Inc. Logo

111, Inc.

YI

(2.5)
Stock Price

0,79 USD

-11.89% ROA

57.54% ROE

-2.04x PER

Market Cap.

392.633.418,21 USD

-39.86% DER

0% Yield

-2.25% NPM

111, Inc. Stock Analysis

111, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

111, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (69.57%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

With a remarkably low PBV ratio (-3.08x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a minimal amount of debt (-89%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Revenue Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

5 Net Profit Growth

Over the last three years, this company has consistently achieved net profit growth, indicating a favorable financial performance and making it an attractive investment option.

6 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

7 ROA

The stock's ROA (-9.44%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (-736) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

111, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

111, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Buy

111, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

111, Inc. Revenue
Year Revenue Growth
2016 873.837.000
2017 959.486.000 8.93%
2018 1.785.970.000 46.28%
2019 3.952.053.000 54.81%
2020 8.203.157.000 51.82%
2021 12.425.902.000 33.98%
2022 13.516.698.000 8.07%
2023 14.660.980.000 7.8%
2023 14.948.129.000 1.92%
2024 13.697.480.000 -9.13%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

111, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2016 61.767.000
2017 48.133.000 -28.33%
2018 71.248.000 32.44%
2019 61.902.000 -15.1%
2020 92.080.000 32.77%
2021 189.284.000 51.35%
2022 139.504.000 -35.68%
2023 0 0%
2023 124.341.000 100%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

111, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2016 191.048.000
2017 157.447.000 -21.34%
2018 243.937.000 35.46%
2019 314.399.000 22.41%
2020 447.236.000 29.7%
2021 752.101.000 40.54%
2022 746.541.000 -0.74%
2023 183.356.000 -307.15%
2023 224.202.000 18.22%
2024 69.224.000 -223.88%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

111, Inc. EBITDA
Year EBITDA Growth
2016 -353.265.000
2017 -230.960.000 -52.96%
2018 -384.492.000 39.93%
2019 -487.877.000 21.19%
2020 -463.838.000 -5.18%
2021 -617.474.000 24.88%
2022 -354.751.000 -74.06%
2023 -312.088.000 -13.67%
2023 -311.871.000 -0.07%
2024 22.452.000 1489.06%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

111, Inc. Gross Profit
Year Gross Profit Growth
2016 77.607.000
2017 90.767.000 14.5%
2018 104.270.000 12.95%
2019 165.183.000 36.88%
2020 365.832.000 54.85%
2021 621.095.000 41.1%
2022 839.976.000 26.06%
2023 762.496.000 -10.16%
2023 848.978.000 10.19%
2024 830.392.000 -2.24%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

111, Inc. Net Profit
Year Net Profit Growth
2016 -362.681.000
2017 -248.580.000 -45.9%
2018 -380.091.000 34.6%
2019 -492.394.000 22.81%
2020 -459.038.000 -7.27%
2021 -662.967.000 30.76%
2022 -408.503.000 -62.29%
2023 -373.204.000 -9.46%
2023 -392.693.000 4.96%
2024 -56.080.000 -600.24%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

111, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2016 -4
2017 -3 -33.33%
2018 -8 57.14%
2019 -6 -16.67%
2020 -6 -20%
2021 -8 28.57%
2022 -5 -75%
2023 -4 0%
2023 -5 0%
2024 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

111, Inc. Free Cashflow
Year Free Cashflow Growth
2016 -395.571.000
2017 -211.232.000 -87.27%
2018 -357.836.000 40.97%
2019 -534.802.000 33.09%
2020 -142.282.000 -275.87%
2021 -704.628.000 79.81%
2022 -54.726.000 -1187.56%
2023 -457.069.000 88.03%
2023 35.208.000 1398.2%
2024 93.260.000 62.25%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

111, Inc. Operating Cashflow
Year Operating Cashflow Growth
2016 -388.646.000
2017 -204.372.000 -90.17%
2018 -343.017.000 40.42%
2019 -510.192.000 32.77%
2020 -116.777.000 -336.89%
2021 -641.936.000 81.81%
2022 -23.152.000 -2672.7%
2023 -447.244.000 94.82%
2023 35.208.000 1370.29%
2024 93.260.000 62.25%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

111, Inc. Capital Expenditure
Year Capital Expenditure Growth
2016 6.925.000
2017 6.860.000 -0.95%
2018 14.819.000 53.71%
2019 24.610.000 39.78%
2020 25.505.000 3.51%
2021 62.692.000 59.32%
2022 31.574.000 -98.56%
2023 9.825.000 -221.36%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

111, Inc. Equity
Year Equity Growth
2016 575.520.000
2017 318.819.000 -80.52%
2018 1.223.764.000 73.95%
2019 773.923.000 -58.12%
2020 1.330.645.000 41.84%
2021 848.705.000 -56.79%
2022 648.235.000 -30.93%
2023 315.244.000 -105.63%
2023 276.104.000 -14.18%
2024 246.733.000 -11.9%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

111, Inc. Assets
Year Assets Growth
2016 941.605.000
2017 763.384.000 -23.35%
2018 1.546.418.000 50.64%
2019 1.610.293.000 3.97%
2020 3.026.489.000 46.79%
2021 3.145.833.000 3.79%
2022 3.473.814.000 9.44%
2023 3.360.949.000 -3.36%
2023 3.089.036.000 -8.8%
2024 2.789.230.000 -10.75%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

111, Inc. Liabilities
Year Liabilities Growth
2016 366.085.000
2017 444.565.000 17.65%
2018 322.654.000 -37.78%
2019 836.370.000 61.42%
2020 1.695.844.000 50.68%
2021 2.297.128.000 26.18%
2022 2.825.579.000 18.7%
2023 3.045.705.000 7.23%
2023 2.812.932.000 -8.28%
2024 2.542.497.000 -10.64%

111, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
171.83
Net Income per Share
-3.87
Price to Earning Ratio
-2.04x
Price To Sales Ratio
0.03x
POCF Ratio
16.99
PFCF Ratio
13.06
Price to Book Ratio
-1.1
EV to Sales
0.01
EV Over EBITDA
-0.54
EV to Operating CashFlow
3.58
EV to FreeCashFlow
4.75
Earnings Yield
-0.49
FreeCashFlow Yield
0.08
Market Cap
0,39 Bil.
Enterprise Value
0,14 Bil.
Graham Number
25.01
Graham NetNet
-10.5

Income Statement Metrics

Net Income per Share
-3.87
Income Quality
-0.13
ROE
0.58
Return On Assets
-0.12
Return On Capital Employed
-0.9
Net Income per EBT
1.13
EBT Per Ebit
1.05
Ebit per Revenue
-0.02
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
0.01
Research & Developement to Revenue
0.01
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.05
Operating Profit Margin
-0.02
Pretax Profit Margin
-0.02
Net Profit Margin
-0.02

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.47
Free CashFlow per Share
0.35
Capex to Operating CashFlow
0.25
Capex to Revenue
0
Capex to Depreciation
0.45
Return on Invested Capital
0.76
Return on Tangible Assets
-0.12
Days Sales Outstanding
12
Days Payables Outstanding
41.64
Days of Inventory on Hand
35.63
Receivables Turnover
30.42
Payables Turnover
8.77
Inventory Turnover
10.25
Capex per Share
0.11

Balance Sheet

Cash per Share
6,95
Book Value per Share
2,88
Tangible Book Value per Share
2.86
Shareholders Equity per Share
-7.19
Interest Debt per Share
3.17
Debt to Equity
-0.4
Debt to Assets
0.09
Net Debt to EBITDA
0.95
Current Ratio
1.07
Tangible Asset Value
0,24 Bil.
Net Current Asset Value
0,11 Bil.
Invested Capital
295103000
Working Capital
0,18 Bil.
Intangibles to Total Assets
0
Average Receivables
0,51 Bil.
Average Payables
1,62 Bil.
Average Inventory
1399975500
Debt to Market Cap
0.63

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

111, Inc. Dividends
Year Dividends Growth

111, Inc. Profile

About 111, Inc.

111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. As of December 31, 2021, it operated 14 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan provinces. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

CEO
Mr. Junling Liu
Employee
1.520
Address
No.295 ZuChongZhi Road
Shanghai, 201203

111, Inc. Executives & BODs

111, Inc. Executives & BODs
# Name Age
1 Mr. Alex Liu
Finance Director
70
2 Dr. Gang Yu
Co-Founder & Executive Chairman
70
3 Mr. Junling Liu
Co-Founder, Acting Chief Financial Officer, Chairman & Chief Executive Officer
70
4 Mr. Haihui Wang
Co-Chief Operating Officer
70
5 Mr. Pengcheng Zhu
Co-Chief Operating Officer
70
6 Monica Mu
IR Director
70
7 Mr. Anfeng Guo
Chief Innovation Officer
70
8 Mr. Yang Chen
Chief Financial Officer at Yaofang Information Technology (Shanghai) Co., Ltd.
70

111, Inc. Competitors